## 

||||Page|
|---|---|---|---|
|Trustees' Report, including||Strategic report|2-31|
|Reference and administrative||details ofthe charity, its Trustees and advisers|32-33|
|Independent|auditors'<br>report||34-38|
|Consolidated|statement offinancial activities||39|
|Consolidated|balance sheet||40-41|
|Company<br>balance sheet|||42-43|
|Consolidated|statement<br>ofcash flows||44|
|Notes to the|financial statements||45-71|





## 



## 

## 




## 







## 

## 

## 

## 



## 

## 

## 



## 

## 

## 

## 

## 



## 

|||I|I|I|I|I||
|---|---|---|---|---|---|---|---|
|In-patient|Unit (specialist beds)||31||||30|
|In-patient|Unit (nurse led beds)||2||||271|
|Living Well|Service||30||||15|





## 

|Hospice at Home||||1,56||1,22|1,22|
|---|---|---|---|---|---|---|---|
|Specialist Palliative||Care Home Team||1,'I|||86|
|Lymphoedema||||24|||16|
|Patient and Family|Support Services|||25|||22|
|Pain Management||||3|||2|
|Complementary<br>Therapy||||26|||17|
|Medical Outpatient||and Domiciliary||9||||
|Community<br>HUB||||6|||2|
|Alan Hudson<br>Day|Treatment||Centre|365|||32|
|Caring Communities||||37|||5|
|Palliative<br>Care Needs Rounds||||59||||
|Transitioning<br>Young||Adults||||||
|Total||||5,011||4,11||
|||||||I||
|Living Well Service||||7|||21|
|Hospice at Home||||21,84||13,90||
|Specialist Palliative||Care Home Team||1,77||1,173||
|Lymphoedema||||6|||34|
|Patient and Family|Support Services|||47|||181|
|Pain Management||||4|||1|
|Complementary<br>Therapy||||56|||28|
|Medical Outpatients||and Domiciliary||25|||15|
|Community<br>HUB||||||||
|Alan Hudson<br>Day|Treatment||Centre|2,82||2,29||
|Transitionin<br>Youn||Adults||||||
|Total||||29,205||18,561||
|||||||I||
|Living Well Service||||1,60||2,53||
|Hospice at Home||||4,10||5,59||
|Specialist Palliative||Care Home Team||9,62||9,68||
|Lymphoedema||||1,551||1,84||
|Patient and Family|Support Services|||50|||91|
|Pain Management||||2|||4|
|Complementary<br>Therapy||||91|||46|
|Medical Outpatients||and Domiciliary||77|||74|
|Community<br>HUB||||1||1,92||
|Alan Hudson<br>Day|Treatment||Centre|4,12||4,84||
|Transitioning<br>Young||Adults||6|||1|
|Total||||23,445||28,62||
|||||||I||
|Number of beds||||1|||1|
|Bed occupancy||||86||8||
|Number ofpatients||||221|||22|
|Number of discharges||||211|||21|
|Average duration|(days)|||17.||16.||
|Available<br>bed da|s|||4,38||4,47||
|||||||I||
|Number of beds|||||7|||
|Bed occupancy|||||82'/|725'||
|Number ofpatients|||||20||19|
|Number<br>of discharges|||||19||18|
|Avera<br>eduration(da||s)|||9.||10.|








## 







## 







|Risk that||ifthere is a prolonged|ifthere is a prolonged|period with|period with|~|Monthly<br>expenditure<br>is closely|||
|---|---|---|---|---|---|---|---|---|---|
|reduction||in income from the various income|||||monitored<br>from timely financial|reporting||
|streams,|there could be impact|||on the financial||~|The Finance and General Purposes|||
|stability|ofthe organisation||resulting<br>in a||||Committee<br>regularly<br>consider the|||
|detrimental<br>impact on the organisation's<br>ability to<br>deliver services and the strategic objectives|||||||implications<br>ofthis and regularly<br>reviews<br>the level of reserves|||
|||||||~|Trustees are kept fully informed|via||
||||||||Trustee meetings|||
|||||||~|Regular contract reviews take|place with||
||||||||service commissioners.|||
|||||||~|There is a diversity ofincome streams||in|
||||||||place|||
|Reliance||on ITsystems to deliver services||||~|ITsupport<br>is outsourced<br>to an|ISO||
||||||||27001 accredited<br>company|||
|||||||~|Regular reviews ofsystems and security|||
||||||||take place with the ITsupport|provider||
|||||||~|Systems are regularly<br>backed|up||





## 

|||||~|Data security awareness<br>training|is in|
|---|---|---|---|---|---|---|
|Vulnerability|to|cyber|crime||place for all staff||
|||||~|Anti-virus<br>protection<br>is in place||
|||||~|Systems and data are regularly|backed|
||||||up and services monitored||



## 



## 

## 

## 

## 



## 




## 

## 



## 

## 

## 

## 

## 

## 



## 

## 

## 

## 

## 



## 

## 

## 



## 

## 



## 

## 

## 



## 

## 

## 

||||Unrestricted|Restricted|Total|Total|
|---|---|---|---|---|---|---|
||||funds|funds|funds|funds|
|||Note|2022<br>5|2022<br>6|2022f|2021<br>E|
|INCOME FROM:|||||||
|Donations<br>and legacies||3|2,043,321|220,943|2,264,264|1,864,629|
|Chadtable<br>activitres||4|1,689,035|6,025,146|7,714,181|6,628,525|
|Other trading<br>activities||5|1,583,218|11,809|1,595,027|807,056|
|Investments||6|3,761||3,761|2,191|
|TOTAL INCOME|||5,319,335|6,257,898|11,577,233|9,302,401|
|EXPENDITURE ON:|||||||
|Raising funds||8|1,801,172|20,002|1,821,174|1,201,597|
|Charitable<br>activities||9|2,064,819|6,404,400|8,469,219|7,781,957|
|TOTAL EXPENDITURE|||3,865,991|6,424,402|10,290,393|8,983,554|
|NET INCOME/(EXPENDITURE)|||1,453,344|(166,504)|1,286,840|318,847|
|Transfers<br>between|funds|22|(202,642)|202,642|||
|NET MOVEMENT|IN FUNDS||1,250,702|36,138|1,286,840|318,847|
|RECONCILIATION|OF FUNDS:||||||
|Total funds brought|forward||9,231,792|687,523|9,919,315|9,600,468|
|Net movement<br>in funds|||1,250,702|36,138|1,286,840|318,847|
|TOTAL FUNDS CARRIED FORWARD|||10,482,494|723,661|11,206,155|9,919,315|





## 

|||Note||2022<br>5||2021f|
|---|---|---|---|---|---|---|
|FIXEDASSETS|||||||
|Tangible assets||15||9,612,812||10,087,452|
|||||9,612,812||10,087,452|
|CURRENT ASSETS|||||||
|Stocks||17|14,647||15,384||
|Debtors||18|2,117,545||1,079,798||
|Investments||19|680,625||||
|Cash at bank and|in hand||2,910,158||2,831,600||
||||5,722,975||3,926,782||
|Creditors: amounts|falling due within one||||||
|year||20|(954,632)||(814,919)||
|NET CURRENT ASSETS||||4,768,343||3,111,863|
|TOTAL ASSETS|LESSCURRENT||||||
|LIABILITIES||||14,381,155||13,199,315|
|Creditors: amounts|falling due after more||||||
|than one year||21||(3,175,000)||(3,280,000)|
|TOTAL NET ASSETS||||11,206,155||9,919,315|
|CHARITY FUNDS|||||||
|Restricted funds||||723,661||687,523|
|Unrestricted<br>funds||||10,482,494||9,231,792|
|TOTAL FUNDS||||11,206,155||9,919,315|





## 

## 

## 

|||Note||2022<br>6||2021f|
|---|---|---|---|---|---|---|
|FIXEDASSETS|||||||
|Tangible assets||15||10,270,117||10,744,757|
|Investments||16||10,000||10,000|
|||||10,280,117||10,754,757|
|CURRENT ASSETS|||||||
|Stocks||17|||724||
|Debtors||18|2,272,331||1,144,184||
|Investments||19|680,625||||
|Cash at bank and|in hand||2,808,237||2,716,803||
||||5,761,193||3,861,711||
|Creditors: amounts|falling due within one||||||
|year||20|(1,036,978)||(793,976)||
|NET CURRENT ASSETS||||4,724,215||3,067,735|
|TOTAL ASSETS|LESSCURRENT||||||
|LIABILITIES||||15,004,332||13,822,492|
|Creditors: amounts|falling due after more||||||
|than one year||21||(3,175,000)||(3,260,000)|
|TOTAL NET ASSETS||||11,829,332||10,542,492|
|CHARITY FUNDS|||||||
|Restricted funds||22||723,661||687,523|
|Unrestricted<br>funds||22||11,105,671||9,854,969|
|TOTAL FUNDS||||11,829,332||10,542,492|





# 

# 

# 



## 

## 

|||||2022|2021|
|---|---|---|---|---|---|
||||Note|6|5|
|CASH FLOWS FROM OPERATING ACTIVITIES||||||
|Net cash used<br>in operating<br>activities|||25|943,763|1,120,308|
|CASH FLOWS FROM INVESTING|ACTIVITIES|||||
|Purchase<br>oftangible<br>fixed assets||||(25,914)|(35,577)|
|Movements<br>in short term cash deposits||||(680,625)||
|NET CASH USED IN INVESTING|ACTIVITIES|||(706,539)|(35,577)|
|CASH FLOWS FROM FINANCING|ACTIVITIES|||||
|Repayments<br>of borrowing||||(158,666)|(158,424)|
|NET CASH USED IN FINANCING|ACTIVITIES|||(158,666)|(158,424)|
|CHANGE<br>IN CASH AND CASH EQUIVALENTS||IN THE YEAR||78,558|926,307|
|Cash and cash equivalents<br>at the beginning<br>ofthe year||||2,831,600|1,905,293|
|CASH AND CASH EQUIVALENTS|AT THE END|OF THE YEAR|26|2,910,158|2,831,600|
|The notes on pages 15to41 form|part ofthese financial statements|||||





## 

## 

## 

## 

## 

## 

## 

## 



## 

## 

## 



## 

## 

## 

## 

## 

## 

## 

## 

## 



## 

## 

## 

## 

## 

## 

## 



## 

## 

## 

## 

## 

## 



## 

## 

## 



## 

## 

||Unrestricted|Restricted|Total|Total|
|---|---|---|---|---|
||funds|funds|funds|funds|
||2022|2022|2022|2021|
||6|6|6|5|
|Donations|969,195|98,920|1,068,115|1,148,419|
|Legacies|946,967|2,500|949,467|423,366|
|Grants|127,159|119,523|246,682|292,844|
||2,043,321|220,943|2,264,264|1,864,629|
|TOTAL 2021|1,649,481|215,148|1,864,629||



## 

||||Unrestricted|Restricted|Total|Total|
|---|---|---|---|---|---|---|
||||funds|funds|funds|funds|
||||2022<br>6|2022f|2022<br>6|2021<br>6|
|Grant from CCG to deliver end-of-life care||||5,970,146|5,970,146|4,760,425|
|Education|||18,554||18,554|4,959|
|Other statutory|income||483,596|55,000|538,596|1,094,041|
|Other|||479,275||479,275|97,949|
|Contract Income from Nurse||led beds|707,610||707,610|671,151|
||||1,689,035|6,025,146|7,714,181|6,628,525|
|TOTAL 2021|||952,967|5,675,558|6,628,525||





## 

## 

## 

## 

## 

||Unrestricted|Restricted|Total|Total|
|---|---|---|---|---|
||funds|funds|funds|funds|
||2022|2022|2022|2021|
||5|f.|6|5|
|Events and fundraising|320,540|6,131|326,671|313,420|
|Other|80,510|2,636|83,146|19,140|
|Shop and trading|956,984||956,984|261,301|
|Lottery income|225,184|3,042|228,226|213,195|
||1,583,218|11,809|1,595,027|807,056|
|TOTAL 2021|800,778|6,278|807,056||



## 

|||Unrestricted|Total|Total|
|---|---|---|---|---|
|||funds|funds|funds|
|||2022|2022|2021|
|||5|5|6|
|Interest||3,761|3,761|2,191|
|TOTAL|2021|2.191|2,191||





## 

## 

## 

## 

## 

||||||Direct|Support|Total|Total|
|---|---|---|---|---|---|---|---|---|
||||||costs|costs|funds|funds|
||||||2022|2022|2022|2021|
||||||6|6|6|6|
|Fundraising,||Retail and||Trading|1,108,616|712,558|1,821,174|1,201,597|
|Hospice care||services|||6,961,140|1,508,079|8,469,219|7,781,957|
||||||8,069,756|2,220,637|10,290,393|8,983,554|
|TOTAL 2021|||||6,887,974|2,095,580|8,983,554||
|FUNDRAISING,|||RETAIL AND TRADING COSTS||||||
||||||Direct|Support|Total|Total|
||||||costs|costs|funds|funds|
||||||2022|2022|2022|2021|
||||||6|6|6|E|
|Challenges|||||16,877|10,983|27,860|25,170|
|Collections||||||||243|
|Community|fundraising|||costs|49,093|31,954|81,047|99,018|
|Events|||||126,550|82,419|208,969|112,898|
|Fundraising||costs|||192,958|116,278|309,236|292,834|
|Corporate|||||19,005|12,378|31,383|33,521|
|Legacies|||||21,796|14,195|35,991|26,914|
|In Memory|||||35,256|22,921|58,177||
|Trusts|||||5,029|3,275|8,304|17,117|
|Engagement||||||||56,117|
|Retail|||||642,052|418,155|1,060,207|537,765|
||||||1,108,616|712,558|1,821,174|1,201,597|
|TOTAL 2021|||||965,248|236,349|1,201,597||



## 



## 

## 

## 

## 

||||Direct|Support|Total|Total|
|---|---|---|---|---|---|---|
||||costs|costs|funds|funds|
||||2022|2022|2022|2021|
||||6|6|6|6|
|Living Well service|||321,206|205,636|526,842|398,893|
|Education|||107,172|18,044|125,216|200,335|
|Hospice at home|||1,957,875|238,806|2,196,681|1,955,813|
|Alan Hudson<br>Day Treatment||Centre|425,499|51,713|477,212|518,646|
|In patient<br>unit|||1,870,242|275,119|2,145,361|2,404,224|
|Nurse led beds|||707,075|460,502|1,167,577|864,792|
|Lymphoedema|||216,156|26,573|242,729|262,598|
|Patient and family support team|||215,068|60,040|275,108|260,804|
|Specialist palliative care team|||667,482|82,463|749,945|730,245|
|Palliative<br>Hub|||344,861|41,891|386,752|55,096|
|Transltioning<br>Young Adults Project|||53,748|6,529|60,277|31,087|
|Complementary|therapy|||||12,019|
|Voluntary<br>services|||74,756|40,763|115,519|87,405|
||||6,961,140|1,508,079|8,469,219|7,781,957|
|TOTAL2021|||5,922,726|1,859,231|7,781,957||





## 

## 

## 

## 

## 

|||Staff||Loan|Total|Total|
|---|---|---|---|---|---|---|
|||costs|Others|financing|funds|funds|
|||2022<br>6|2022|2022f|2022<br>6|2021<br>8|
|Facilities: Estates and catedng||281,488|325,349||606,837|545,411|
|Central|costs|398,129|122,871|114,896|635,896|675,941|
|Finance||148,868|21,250||170,118|170,888|
|Human|resources|161,666|64,727||226,393|200,038|
||||257,538||257,538|269,403|
|Insurance|||57,602||57,602|53,721|
|Public relations||85,928|61,142||147,070|114,116|
|Governance||78,731|40,452||119,183|66,062|
|||1,154,810|950,931|114,896|2,220,637|2,095,580|
|TOTAL|2021|1,027,085|948,015|120,480|2,095,580||



## 

||Charitable|Fundraising|Support|Total|Total|
|---|---|---|---|---|---|
||direct costs|direct costs|costs|funds|funds|
||2022<br>6|2022|2022<br>6|2022f|2021<br>6|
|Staff costs|5,778,225|718,459|1,154,810|7,651,494|6,557,720|
|Leases and rent|52,191|119,097||171,288|138,058|
|Loan financing costs|||114,896|114,896|120,480|
|Other|1,083,018|254,822|514,319|1,852,159|1,642,105|
|Depreciation|47,706|16,238|436,612|500,556|525,191|
||6,961,140|1,108,616|2,220,637|10,290,393|8,983,554|
|TOTAL 2021|5,922,726|965,248|2,095,580|8,983,554||





## 

## 

## 

## 

|This is st|ated after char|ging:|||||
|---|---|---|---|---|---|---|
||||||2022|2021|
||||||6|6|
|Auditors'|remuneration|-audit|||20,827|18,861|
|Auditors'|remuneration|-other services|||16,272|15,535|
|Depreciation<br>oftangible||fixed assets: owned|by the charitable|group|500,556|525,191|



## 

## 

|||||Group|Group|Company|Company|
|---|---|---|---|---|---|---|---|
|||||2022|2021|2022|2021|
|||||6|||6|
|Wages and|salaries|||6,452,838|5,525,095|6,436,776|5,525,095|
|Social security costs||||577,080|487,613|577,080|487,613|
|Contribution|to defined|contribution|pension|||||
|schemes||||638,633|556,317|636,068|556,317|
|||||7,668,551|6,570,025|7,649,924|6,570,025|



|||Group|Group|
|---|---|---|---|
|||2022|2021|
|||No.|No.|
|Clinical services||176|147|
|Fundraising|and communications|22|23|
|Support and|governance|37|34|
|Bank staff||35|12|
|Retail||14|12|
|||284|228|





## 

## 

## 

## 

|||Group|Group|
|---|---|---|---|
|||2022|2021|
|||No.|No.|
|Clinical services||138|114|
|Fundraising|and communications|16|18|
|Support and|governance|32|29|
|Bank staff||23|8|
|Retail||12|10|
|||221|179|



|Group|Group|
|---|---|
|2022|2021|
|No.|No.|



## 



## 

## 

## 

## 

## 

|||Long-term|||
|---|---|---|---|---|
||Freehold|leasehold|Fixtures and||
||property|property|fittings|Total|
||E|E|6||
|COST OR VALUATION|||||
|At 1 April 2021|11,193,156|120,000|1,046,526|12,359,682|
|Additions|||25,916|25,916|
|At 31 March 2022|11,193,156|120,000|1,072,442|12,385,598|
|DEPRECIATION|||||
|At 1 April 2021|1,658,538|5,300|608,392|2,272,230|
|Charge for the year|369,891|1,200|129,465|500,556|
|At 31 March 2022|2,028,429|6,500|737,857|2,772,786|
|NET BOOK VALUE|||||
|At 31 March 2022|9,164,727|113,500|334,585|9,612,812|
|At 31 March 2021|9,534,618|114,700|438,134|10,087,452|





## 

## 

## 

## 

## 

|||Long-term|||
|---|---|---|---|---|
||Freehold|leasehold|Fixtures and||
||property<br>E|property<br>6|fittings<br>6|Total<br>f|
|COST OR VALUATION|||||
|At 1 April 2021|11,850,461|120,000|1,046,526|13,016,987|
|Additions|||25,916|25,916|
|At 31 March 2022|11,850,461|120,000|1,072,442|13,042,903|
|DEPRECIATION|||||
|At 1 April 2021|1,658,538|5,300|608,392|2,272,230|
|Charge for the year|369,891|1,200|129,465|500,556|
|At 31 March 2022|2,028,429|6,500|737,857|2,772,786|
|NET BOOK VALUE|||||
|At 31 March 2022|9,822,032|113,500|334,585|10,270,117|
|At 31 March 2021|10,191,923|114,700|438,134|10,744,757|





## 

## 

## 

## 

||Investments|
|---|---|
||in|
||subsidiary|
||companies|
|COMPANY|E|
|COST OR VALUATION||
|At 1 Apdl 2021|10,000|
|AT 31 MARCH 2022|10,000|
|NET BOOK VALUE||
|AT 31 MARCH 2022|10,000|
|AT 31 MARCH 2021|10,000|



## 



## 

## 

## 

## 

## 

||Name||||Income<br>Expenditure|Income<br>Expenditure|Profit/(Loss)|
|---|---|---|---|---|---|---|---|
||||||5|6|ISurplus/|
||||||||(Deficit) for|
||||||||the year|
||||||||6|
||Arthur<br>Rank||Hospice Limited||199,698|(143,047)|56,651|
|17.|STOCKS|||||||
|||||Group|Group|Company|Company|
|||||2022|2021|2022|2021|
|||||6|E|6|F|
||Finished|goods and goods for resale||14,647|15,384||724|
|||||14,647|15,384||724|
|18.|DEBTORS|||||||
|||||Group|Group|Company|Company|
|||||2022|2021|2022|2021|
|||||6|F|6|f|
||DUE WITHIN||ONE YEAR|||||
||Trade debtors|||599,592|359,084|586,921|358,975|
||Amounts|owed by group undertakings||||49,318|65,989|
||Other debtors|||759,534|106,640|878,548|105,743|
||Prepayments||and accrued income|96,945|89,871|96,070|89,274|
||Tax recoverable|||20,638|12,577|20,638|12,577|
||Grants receivable|||640,836|511,626|640,836|511,626|
|||||2,117,545|1,079,798|2,272,331|1,144,184|





## 

## 

## 

## 

||||Group|Group|Company|Company|
|---|---|---|---|---|---|---|
||||2022|2021|2022|2021|
||||6|6|E|6|
|I|isted|investments|680,625||680,625||
||||680,625||680,625||



## 

|||Group|Group|Company|Company|
|---|---|---|---|---|---|
|||2022|2021|2022|2021|
|||||6||
|Other loans||198,969|197,633|198,969|197,633|
|Trade creditors||211,054|182,371|208,736|180,351|
|Other taxation and social security||195,695|160,137|189,955|160,137|
|Other creditors||172,201|163,823|298,340|161,736|
|Accruals and deferred|income|176,713|110,955|140,978|94,119|
|||954,632|814,919|1,036,978|793,976|



## 

|||Group|Group|Company|Company|
|---|---|---|---|---|---|
|||2022|2021|2022|2021|
|||6|6|6|F|
|Other|loans|3,120,000|3,280,000|3,120,000|3,280,000|
|Other|creditors|55,000||55,000||
|||3,175,000|3,280,000|3,175,000|3,280,000|





## 

## 

## 

|Included<br>within the above are amounts<br>fallin|g due as follows:||||
|---|---|---|---|---|
||Group|Group|Company|Company|
||2022|2021|2022|2021|
||6|6|E|6|
|BETWEEN ONE AND TWO YEARS|||||
|Otherloans|160,000|160,000|160,000|160,000|
|BETWEEN TWO AND FIVE YEARS|||||
|Other loans|480,000|480,000|480,000|460,000|
|OVER FIVE YEARS|||||
|Other loans|2,480,000|2,640,000|2,480,000|2,640,000|



||||||Group|Group|Company|Company|
|---|---|---|---|---|---|---|---|---|
||||||2022|2021|2022|2021|
||||||6|F|6|6|
|Payable|or|repayable|by|instalments|2,480,000|2,640,000|2,480,000|2,640,000|
||||||2,480,000|2,640,000|2,480,000|2,640,000|





## 

## 

## 

## 

|STATEMENT OF FUNDS - CU|RRENT YEAR|||||
|---|---|---|---|---|---|
||||||Balance at|
||Balance at 1|||Transfers|31 March|
||April 2021|Income|Expenditure|in/out|2022|
|||E|E|||
|UNRESTRICTED FUNDS||||||
|DESIGNATED FUNDS||||||
|Hospice fund|6,775,067|||(315,977)|6,459,090|
|Legacy reserve|211,000||||211,000|
||6,986,067|||(315,977)|6,670,090|
|GENERAL FUNDS||||||
|General funds|2,211,597|5,119,637|(3,722,944)|169,986|3,778,276|
|Subsidary<br>undertakings|34,128|199,698|(143,047)|(56,651)|34,128|
||2,245,725|5,319,335|(3,865,991)|113,335|3,812,404|
|TOTAL UNRESTRICTED||||||
|FUNDS|9,231,792|5,319,335|(3,865,991)|(202,642)|10,482,494|
|RESTRICTED FUNDS||||||
|Grant to deliver end of life care||5,970,146|(6,172,788)|202,642||
|Hospice at home|161,088|32,898|(40,775)||153,211|
|Alan Hudson<br>Day Treatment||||||
|Centre|384,014|125,153|(127,041)||382,126|
|Arthur's<br>shed|5,097||(37)||5,060|
|Equipment|57,361|3,500|(6,043)||54,818|
|Other restricted<br>funds|79,963|126,201|(77,718)||128,446|
||687,523|6,257,898|(6,424,402)|202,642|723,661|
|TOTAL OF FUNDS|9,919,315|11,577,233|(10,290,393)||11,206,155|





## 

## 

|STATEMENT OF FUNDS - PRIO|R YEAR|||||
|---|---|---|---|---|---|
||||||Balance at|
||Balance at|||Transfers|31 March|
||1 April 2020|Income<br>6|Expenditure<br>E|in/out<br>f|2021|
|UNRESTRICTED FUNDS||||||
|DESIGNATED FUNDS||||||
|Hospice fund|7,092,656|||(317,589)|6,775,067|
|Legacy reserve||||211,000|211,000|
||7,092,656|||(106,589)|6,986,067|
|GENERAL FUNDS||||||
|General funds|1,851,565|3,298,686|(2,613,792)|(324,862)|2,211,597|
|Subsidary<br>undertakings|34,128|106,731|(106,731)||34,128|
||1,885,693|3,405,417|(2,720,523)|(324,862)|2,245,725|
|TOTAL UNRESTRICTED||||||
|FUNDS|8,978,349|3,405,417|(2,720,523)|(431,451)|9,231,792|
|RESTRICTED FUNDS||||||
|Grant to deliver end of life care|28,270|4,760,425|(5.220,146)|431,451||
|Hospice at home|123,999|43,651|(6,562)||161,088|
|Alan Hudson<br>Day Treatment||||||
|Centre|387,195|103,518|(106,699)||384,014|
|Arthur's<br>shed|5,097||||5,097|
|Education|2,690|4.398|(7,088)|||
|Equipment|60,544|1,249|(4,432)||57,361|
|NHSE||860,133|(860,133)|||
|Other|14,324|123,610|(57,971)||79,963|
||622,119|5,896,984|(6,263,031)|431,451|687,523|
|TOTAL OF FUNDS|9,600,468|9,302,401|(8,983,554)||9,919,315|





## 

## 

## 

## 

## 

## 

## 

## 

## 

## 



## 

## 

## 

## 

## 

## 

## 

|||||Balance at|||||Transfers|Balance at|Balance at|
|---|---|---|---|---|---|---|---|---|---|---|---|
||||1 April 2021|||Income||Expenditure|in/out||31 March|
|||||6|||E||F||2022|
||||||||||||6|
|Unrestricted<br>funds||||9,854,969|5,119,637|||(3,666,393)|(202,642)|11,105,571||
|Restricted<br>funds||||687,523|6,257,898|||(6,424,402)|202,642||723,661|
|Total||||10,542,492|11,377,535|||(10,090,795)||11,829,332||
|CHARITY ONLY FUNDS - PRIOR||||||YEAR||||||
|||||Balance at|||||Transfers|Balance at||
||||1 April 2020<br>E|||Incomef||Expenditure<br>6|in/out<br>6|31 March 2021<br>5||
|Unrestricted<br>funds||||9,601,526|3,298,686|||(2,613,792)|(431,451)||9,854.969|
|Restricted<br>funds||||622,119|5.896.984|||(6,263,031)|431,451||687,523|
|Total||||10,223,645|9,195,670|||(8,876,823)||10,542,492||
|ANALYSIS OF|||NET ASSETS BETWEEN||||FUNDS|||||
|ANALYSIS OF|||NET ASSETS BETWEEN||||FUNDS|- CURRENT YEAR (GROUP)||||
|||||||||Unrestricted<br>Restricted|||Total|
||||||||||funds|funds|funds|
||||||||||2022|2022|2022|
||||||||||E|F|6|
|Tangible|fixed|assets|||||||9,612,812||9,612,812|
|Current|assets||||||||4,999,314|723,661|5,722,975|
|Creditors|due|within one year|||||||(954,632)||(954,632)|
|Creditors|due|in||more than one year|||||(3,175,000)||(3,175,000)|
|TOTAL||||||||10,482,494||723,661|11,206,155|





## 

## 

## 

## 

## 

||||Unrestricted|Restricted|Total|
|---|---|---|---|---|---|
||||funds|funds|funds|
||||2021|2021|2021|
||||6|6|F|
|Tangible|fixed|assets|10,087,452||10,087,452|
|Current|assets||3,239,259|687,523|3,926,782|
|Creditors|due|within one year|(814,919)||(814,919)|
|Creditors|due|in more than one year|(3,280,000)||(3,280,000)|
||||9,231,792|687,523|9,919,315|



## 

## 

|||Unrestricted|Restricted|Total|
|---|---|---|---|---|
|||funds|funds|funds|
|||2022|2022|2022|
|||E|6|6|
|Tangible fixed|assets|10,270,116||10,270,116|
|Investments||10,000||10,000|
|Current assets||5,037,532|723,661|5,761,193|
|Creditors due|within one year|(1,036,978)||(1,036,978)|
|Creditors due|in more than one year|(3,175,000)||(3,175,000)|
|||11,105,670|723,661|11,829,331|





## 

## 

## 

## 

||Unrestricted|Restricted|Total|
|---|---|---|---|
||funds|funds|funds|
||2021f|2021<br>6|2021<br>6|
|Tangible fixed assets|10,744,757||10,744,757|
|Investments|10,000||10,000|
|Current assets|3,174,188|687,523|3,861,711|
|Creditors due within one year|(793,976)||(793,976)|
|Creditors due in more than one year|(3,280,000)||(3,280,000)|
||9,854,969|687,523|10,542,492|



## 

||||Group|Group|
|---|---|---|---|---|
||||2022|2021|
|||||6|
|Net income|for the year (as per Statement of Financial Activities)||1,286,840|318,847|
|ADJUSTMENTS FOR:|||||
|Depreciation|charges||500,556|525,191|
|Decrease/(increase)||in stocks|737|(2,228)|
|Decrease/(increase)||in debtors|(1,037,747)|140,428|
|Increase<br>in|creditors||193,377|138,070|
|NET CASH|PROVIDED BYOPERATING ACTIVITIES||943,763|1,120,308|



## 

## 

||Group|Group|
|---|---|---|
||2022|2021|
||6|6|
|Cash in hand|2,910,158|2,831,600|
|TOTAL CASH AND CASH EQUIVALENTS|2,910,158|2,831,600|





## 

## 

## 


## 

## 

## 

## 

|payments|und|er non-cancellable<br>operating<br>leases as follows:|||
|---|---|---|---|---|
||||Group|Group|
||||2022|2021|
||||E|6|
|Not later than||1 year|144,704|153.441|
|Later than|1 year and not later than 5years||422,764|481,853|
|Later than|5years||235,793|294,053|
||||803,261|929,347|





## 

## 

## 

## 

